Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells

被引:20
作者
Byrne, MF
Murphy, JF
Corcoran, PA
Atherton, JC
Sheehan, KM
Cox, D
Murray, FE
Fitzgerald, DJ
机构
[1] Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
[2] Univ Hosp, Div Gastroenterol, Nottingham, England
[3] Univ Hosp, Inst Infect & Immunol, Nottingham, England
[4] Beaumont Hosp, Dept Gastroenterol, Dublin 9, Ireland
基金
英国医学研究理事会;
关键词
cyclooxygenase; endothelium; H; pylori;
D O I
10.1080/00365520310005622
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Helicobacter pylori induces cyclooxygenase activity in the stomach, although the COX isoform and cellular source are unclear. A potential source is the vascular endothelial cell, which plays a role in regulating mucosal blood flow and inflammatory cell infiltration. Methods: We examined the effect of four strains ( toxigenic and non-toxigenic) of H. pylori on COX isoform expression in vascular endothelial cells. Prostaglandin synthesis was measured by enzyme immunoassay and COX isozyme expression determined by Western blot and RT-PCR. Gene induction was examined using 5' deletion constructs of the COX-1 and COX-2 promoters coupled with luciferase. Results: All H. pylori strains induced prostaglandin generation and expression of both COX-1 and COX-2 in HUVEC, although this was most pronounced with the highly toxigenic strain H. pylori 60190. Treatment of the cells with selective COX inhibitors demonstrated that COX-1 was predominantly responsible for the enhanced generation of prostacyclin induced by H. pylori 60190. Similar results were seen with H. pylori broth culture filtrates, suggesting that a secreted product was responsible. Induction of COX-2 reflected both enhanced gene expression and stabilization of the mRNA. Conclusions: H. pylori increased both COX-1 and COX-2 activity in vascular endothelial cells. This increased generation of endothelial cell prostacyclin may play a role in modulating mucosal blood flow, platelet function and inflammatory cell infiltration in response to H. pylori infection. The regulation of COX-1 at the transcriptional level by H. pylori described in this study is a novel finding and calls into question the traditional description of COX-1 as a purely constitutive, housekeeping gene.
引用
收藏
页码:1023 / 1030
页数:8
相关论文
共 46 条
[1]   Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 [J].
Adderley, SR ;
Fitzgerald, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :5038-5046
[2]  
ALBRIGHTSON CR, 1985, J IMMUNOL, V135, P1872
[3]  
COVER TL, 1994, J BIOL CHEM, V269, P10566
[4]   Helicobacter pylori induces interleukin-8 expression in endothelial cells and the signal pathway is protein tyrosine kinase dependent [J].
Ding, SZ ;
Cho, CH ;
Lam, SK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (03) :561-565
[5]   Post-transcriptional control of cyclooxygenase-2 gene expression -: The role of the 3′-untranslated region [J].
Dixon, DA ;
Kaplan, CD ;
McIntyre, TM ;
Zimmerman, GA ;
Prescott, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :11750-11757
[6]   Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells [J].
Dixon, DA ;
Tolley, ND ;
King, PH ;
Nabors, LB ;
McIntyre, TM ;
Zimmerman, GA ;
Prescott, SM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (11) :1657-1665
[7]   Platelet activation in mice and human Helicobacter pylori infection [J].
Elizalde, I ;
Gomez, J ;
Panes, J ;
Lozano, M ;
Casadevall, M ;
Ramirez, J ;
Pizcueta, P ;
Marco, F ;
deRojas, FD ;
Granger, DN ;
Pique, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :996-1005
[8]   Transcriptional regulation of prostaglandin-H-synthase-1 in the amnion-derived AV3 cell line [J].
Eykholt, RL ;
Potter, S ;
Marvin, KW ;
Mitchell, MD .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 63 (03) :123-131
[9]  
Fernández-Morata JC, 2000, CLIN EXP ALLERGY, V30, P1275
[10]   Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs:: HELP NSAIDs study [J].
Hawkey, CJ ;
Tulassay, Z ;
Szczepanski, L ;
van Rensburg, CJ ;
Filipowicz-Sosnowska, A ;
Lanas, A ;
Wason, CM ;
Peacock, RA ;
Gillon, KRW .
LANCET, 1998, 352 (9133) :1016-1021